Successful therapy confirmed for newborns with the fatal metabolic disorder MoCD type A

Off Health, Health Information, Human Health, Science and Health, Science and Research, Science Daily, Uncategorized

Early administration of the drug Fosdenopterin/rcPMP improves the chances of survival of infants with MoCD type A and promotes the development of brain functions.
Read Original Article: Successful therapy confirmed for newborns with the fatal metabolic disorder MoCD type A »

About The Author